Letter: pancreatic involvement in inflammatory bowel disease
- PMID: 35748841
- DOI: 10.1111/apt.17078
Letter: pancreatic involvement in inflammatory bowel disease
Comment on
-
Systematic review-pancreatic involvement in inflammatory bowel disease.Aliment Pharmacol Ther. 2022 Jun;55(12):1478-1491. doi: 10.1111/apt.16949. Epub 2022 May 3. Aliment Pharmacol Ther. 2022. PMID: 35505465 Free PMC article.
References
REFERENCES
-
- Massironi S, Fanetti I, Vigano C, Pirola L, Fichera M, Cristoferi L, et al. Systematic review: pancreatic involvement in inflammatory bowel disease. Aliment Pharmacol Ther. 2022;55:1478-1491.
-
- Gschwantler M, Kogelbauer G, Klose W, Bibus B, Tscholakoff D, Weiss W. The pancreas as a site of granulomatous inflammation in Crohn's disease. Gastroenterol. 1995;108(4):1246-9.
-
- Kadayakkara DK, Beatty PL, Turner MS, Janjic JM, Ahrens ET, Finn OJ. Inflammation driven by overexpression of the hypoglycosylated abnormal mucin 1 (MUC1) links inflammatory bowel disease and pancreatitis. Pancreas. 2010;39(4):510-5.
-
- Lashner BA, Kirsner JB, Hanauer SB. Acute pancreatitis associated with high-concentration lipid emulsion during total parenteral nutrition therapy for Crohn's disease. Gastroenterol. 1986;90(4):1039-41.